Opportunity remains despite regulatory and access obstacles.
Karina Ikeda
Advertisement
Karina Ikeda is a senior consultant within the life sciences practice at Guidehouse
Articles by Karina Ikeda
Advertisement
Latest Updated Articles
The JAKs Journey Offers Valuable Lessons for InnovatorsFebruary 17th 2022
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
2
Johnson & Johnson’s Experience Navigating The Commissioner’s National Priority Voucher Program
3
How AI Is Transforming Drug Labeling
4
FDA’s Shift Signals a New Era for Data-Driven Drug Development
5